Moreover, our results showed that astrocytomas are enriched with immune cells expressing high levels of TMIGD2, unlike oligodendrogliomas and glioblastomas subtypes (p= 0.0091; p= 0.0006) (Figure 3M). This evidence concerns the gene TMIGD2 and glioblastoma.